Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShort-Term Debt repayments
Ratios

Kiora Pharmaceuticals (KPRX) Short-Term Debt repayments (2025)

Kiora Pharmaceuticals' Short-Term Debt repayments history spans 1 years, with the latest figure at $1.8 million for Q3 2025.

  • For Q3 2025, Short-Term Debt repayments changed N/A year-over-year to $1.8 million; the TTM value through Dec 2025 reached $2.8 million, changed N/A, while the annual FY2025 figure was $2.8 million, N/A changed from the prior year.
  • Short-Term Debt repayments reached $1.8 million in Q3 2025 per KPRX's latest filing, up from $1.0 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $1.8 million in Q3 2025 to a low of $1.0 million in Q2 2025.